Squarepoint’s Applied Therapeutics APLT Stock Holding History

Squarepoint’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-158,865	Closed	-$96.1K	–	4231
2025 Q3	$96.1K	Buy	158,865 +148,583	+1,445%	+$70K	﹤0.01%	4118
2025 Q2	$3.2K	Buy	+10,282	New	+$3.98K	﹤0.01%	4417
2024 Q4	–	Sell	-11,452	Closed	-$97.3K	–	4998
2024 Q3	$97.3K	Sell	11,452 -9,026	-44%	-$53.2K	﹤0.01%	3876
2024 Q2	$95.6K	Sell	20,478 -173,280	-89%	-$820K	﹤0.01%	3811
2024 Q1	$1.32M	Buy	193,758 +179,843	+1,292%	+$807K	﹤0.01%	2375
2023 Q4	$46.6K	Buy	+13,915	New	+$34.6K	﹤0.01%	3857
2021 Q4	–	Sell	-10,700	Closed	-$178K	–	3144
2021 Q3	$178K	Buy	+10,700	New	+$185K	﹤0.01%	2533
2020 Q3	–	Sell	-16,531	Closed	-$598K	–	2471
2020 Q2	$598K	Buy	+16,531	New	+$692K	0.01%	1214
2020 Q1	–	Sell	-14,090	Closed	-$384K	–	1841
2019 Q4	$384K	Buy	+14,090	New	+$241K	﹤0.01%	1908

Other funds holding APLT

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

DAM

Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Squarepoint's APLT Position: Q4 2025 in Review

Squarepoint sold out of Applied Therapeutics (APLT) in Q4 2025, closing a stake of 158,865 shares — an estimated $96.1K sold.

Squarepoint first reported a position in APLT in Q4 2019 and held it in 9 quarters. The position peaked at $1.32M in Q1 2024. 52 funds tracked by Wall St. Rank hold APLT as of Q4 2025.

Squarepoint reported no remaining Applied Therapeutics position as of Q4 2025 after selling out during the quarter.
Squarepoint sold 158,865 Applied Therapeutics shares in Q4 2025, an estimated $96.1K.
Squarepoint first reported a position in Applied Therapeutics in Q4 2019 and held it in 9 quarters.
Squarepoint's Applied Therapeutics position peaked at $1.32M in Q1 2024.
52 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2025.

Based on Squarepoint's 13F filing for Q4 2025, filed 13 Feb 2026.